ArriVent BioPharma, Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
HHLR ADVISORS, LTD. | 02/14/2025 | 4.48 M | $119.47 M | 0.00% | 13.35% |
ORBIMED ADVISORS LLC | 02/14/2025 | 3.03 M | $80.65 M | 0.00% | 9.01% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.25 M | $59.83 M | 21.72% | 6.69% |
BLACKROCK, INC. | 02/07/2025 | 2.14 M | $56.88 M | 10.55% | 6.36% |
FMR LLC | 02/13/2025 | 2.10 M | $55.97 M | -0.88% | 6.26% |
OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 2.06 M | $54.86 M | 4.20% | 6.13% |
SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 1.70 M | $45.20 M | 0.00% | 5.05% |
02/26/2025 | 1.64 M | $43.79 M | 100.00% | 4.90% | |
NOVO HOLDINGS A/S | 02/14/2025 | 1.52 M | $40.51 M | 1.02% | 4.53% |
GENERAL CATALYST GROUP MANAGEMENT, LLC | 01/23/2025 | 1.49 M | $39.82 M | 0.00% | 4.45% |
SC CHINA HOLDING LTD | 02/14/2025 | 663,308 | $16.79 M | 0.00% | 1.98% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 596,182 | $15.89 M | -0.16% | 1.78% |
CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 585,462 | $15.60 M | 0.00% | 1.74% |
NORTHERN TRUST CORP | 02/14/2025 | 241,009 | $6.42 M | 4.55% | 0.72% |
HIDDEN LAKE ASSET MANAGEMENT LP | 02/14/2025 | 184,605 | $4.92 M | 100.00% | 0.55% |
MORGAN STANLEY | 02/14/2025 | 148,584 | $3.96 M | -11.42% | 0.44% |
WOODLINE PARTNERS LP | 02/14/2025 | 145,797 | $3.88 M | 20.55% | 0.43% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 52,545 | $1.40 M | -75.74% | 0.16% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 45,544 | $1.21 M | 5.27% | 0.14% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 44,282 | $1.18 M | 0.00% | 0.13% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 41,921 | $1.12 M | 100.00% | 0.12% |
RHUMBLINE ADVISERS | 01/30/2025 | 36,690 | $977,412 | 9.13% | 0.11% |
CITIGROUP INC | 02/12/2025 | 34,121 | $908,983 | 67.26% | 0.10% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 28,200 | $751,248 | 0.00% | 0.08% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 27,299 | $727,245 | 186.27% | 0.08% |
ALPS ADVISORS INC | 02/13/2025 | 27,252 | $725,993 | -0.66% | 0.08% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 17,114 | $456,252 | 8.41% | 0.05% |
INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 14,798 | $394,219 | 100.00% | 0.04% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 14,007 | $373,146 | -7.02% | 0.04% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 13,627 | $363,024 | 379.15% | 0.04% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 10,018 | $266,880 | -2.11% | 0.03% |
UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 8,165 | $217,516 | 100.00% | 0.02% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 7,783 | $207,000 | 34.58% | 0.02% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 7,145 | $190,343 | 100.00% | 0.02% |
02/11/2025 | 6,255 | $166,633 | 100.00% | 0.02% | |
02/11/2025 | 3,100 | $82,584 | 100.00% | 0.01% | |
VIRTUS ETF ADVISERS LLC | 02/14/2025 | 2,747 | $73,180 | 100.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 1,599 | $42,597 | 773.77% | 0.00% |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 1,123 | $30,613 | 100.00% | 0.00% |
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 01/17/2025 | 996 | $26,533 | 12.16% | 0.00% |
AMALGAMATED BANK | 02/04/2025 | 963 | $26,000 | 0.00% | 0.00% |
02/19/2025 | 708 | $18,861 | 100.00% | 0.00% | |
02/13/2025 | 555 | $14,785 | 1,161.36% | 0.00% | |
STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 373 | $9,937 | 532.20% | 0.00% |
SRS CAPITAL ADVISORS, INC. | 02/05/2025 | 119 | $3,171 | 0.00% | 0.00% |
DAIWA SECURITIES GROUP INC. | 02/07/2025 | 111 | $3,000 | 100.00% | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 96 | $2,557 | 255.56% | 0.00% |
GAMMA INVESTING LLC | 01/03/2025 | 70 | $1,865 | 180.00% | 0.00% |
ROTHSCHILD INVESTMENT LLC | 02/04/2025 | 45 | $1,199 | 350.00% | 0.00% |
RONALD BLUE TRUST, INC. | 01/22/2025 | 39 | $917 | 0.00% | 0.00% |
ArriVent BioPharma, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 54 institutional investors and hedge funds held shares of ArriVent BioPharma, Inc. Common Stock. The most heavily invested institutionals were:
Parallel Advisors, LLC: 0
HHLR ADVISORS, LTD.: 4.48 M
ORBIMED ADVISORS LLC: 3.03 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 2.25 M
BlackRock, Inc.: 2.14 M
FMR LLC: 2.1 M
82.31% of ArriVent BioPharma, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 24.95 M shares in the last 24 months. This purchase volume represents approximately $452.87 M in transactions.